Table 5.
Treatment | Normal | Control | Bisacodyl | Lactobacillus bulgaricus | LF-Suo (×109 CFU/kg b.w.) | |
---|---|---|---|---|---|---|
0.1 (g) | 1.0 (g) | |||||
Small intestine length (cm) | 47.9 ± 2.6 a | 44.6 ± 4.2 a | 47.2 ± 2.2 a | 46.4 ± 3.2 a | 47.0 ± 3.8 a | 47.1 ± 2.5 a |
Distance traveled (cm) | 47.9 ± 2.6 a | 18.8 ± 3.2 f | 44.7 ± 1.3 b | 25.6 ± 2.5 e | 34.0 ± 3.1 d | 40.3 ± 1.9 c |
GI transit (%) | 100.0 ± 0.0 a | 42.1 ± 5.6 f | 94.6 ± 6.7 b | 55.2 ± 4.6 e | 72.3 ± 6.5 d | 85.5 ± 6.3 c |
n = 10 ICR mice in each group, bisacodyl: 100 mg/kg b.w.; Lactobacillus bulgaricus (1.0 × 109 CFU/kg b.w.); LF-Suo: Lactobacillus fermentum Suo; a–f Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple range test.